enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Does Medicare cover Repatha, and what does it cost? - AOL

   www.aol.com/does-medicare-cover-repatha-does...

   Repatha’s website states that with self-purchased or employer-based insurance, 82% of commerical prescriptions of Repatha cost $49 or less per month. Amgen, the makers of Repatha, offers a copay ...

3. Evolocumab - Wikipedia

   en.wikipedia.org/wiki/Evolocumab

   Evolocumab, [6] sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) .

4. Amgen Inc v. Sanofi - Wikipedia

   en.wikipedia.org/wiki/Amgen_Inc_v._Sanofi

   Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112(a).

5. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   In November, Amgen awarded a $2 million grant to the CDC Foundation to launch the latter's EmPOWERED Health Program, promoting patient engagement in decision making for their cancer treatment. [85] In December, the FDA approved Avsola (infliximab-axxq). [86] 2020: In April, Amgen established Amgen K.K. as the company's wholly-owned affiliate in ...

6. Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes

   www.aol.com/news/amgen-apos-repatha-reduces-bad...

   Amgen's (AMGN) Repatha significantly reduces LDL-C and non-HDL-C in patients with type II diabetes and hypercholesterolemia or mixed dyslipidemia.

7. Amgen's Repatha Improves Plaque Stability In Heart Patients - AOL

   www.aol.com/news/amgens-repatha-improves-plaque...

   Amgen Inc (NASDAQ: AMGN) has announced positive data from the HUYGENS Phase 3 study assessing if Repatha (evolocumab) could increase the thickness of the fibrous caps to improve a feature of ...

8. Expanded access - Wikipedia

   en.wikipedia.org/wiki/Expanded_access

   Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.

9. Amgen's Repatha Gains CHMP Nod to Include Outcomes Data - AOL

   www.aol.com/news/amgen-apos-repatha-gains-chmp...

   For premium support please call: 800-290-4726 more ways to reach us